Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 20/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 18/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.42 |
| ▸ | OGFRL1 | Q5TC84 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL735686 | 0.81 | OPRM1 (0.59) | OPRL1OPRM1OPRK1OPRD1OGFRL1 | |
| SCHEMBL735993 | 0.77 | OPRL1 (0.45) | OPRL1OPRM1OPRK1 | |
| SCHEMBL13805830 | 0.76 | OPRM1 (0.71) | OPRL1OPRM1OPRK1OPRD1OGFRL1 | |
| SCHEMBL735963 | 0.74 | KDM4C (0.37) | OPRL1OPRM1OPRK1OPRD1OGFRL1 | |
| SCHEMBL13805914 | 0.73 | OPRM1 (0.71) | OPRL1OPRM1OPRK1OPRD1OGFRL1 | |
| SCHEMBL734100 | 0.72 | OPRM1 (0.40) | OPRL1OPRM1OPRK1OPRD1OGFRL1 | |
| SCHEMBL3407442 | 0.71 | OPRM1 (1.00) | OPRL1OPRM1OPRK1OPRD1OGFRL1 | |
| SCHEMBL3411311 | 0.70 | OPRM1 (0.74) | OPRL1OPRM1OPRK1OPRD1OGFRL1 | |
| SCHEMBL1119612 | 0.70 | OPRL1 (1.00) | OPRL1OPRM1OPRK1 | |
| SCHEMBL1119831 | 0.70 | OPRM1 (0.86) | OPRL1OPRM1OPRK1OPRD1OGFRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2044016-B1 | 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM | GRUENENTHAL GMBH (DE) | 2012-12-05 | — | — | EP | disclosed |
| US-8138187-B2 | Substituted heteroaryl derivatives | GRUENENTHAL GMBH (DE) | 2012-03-20 | — | — | US | disclosed |
| US-20100009986-A1 | SUBSTITUTED HETEROARYL DERIVATIVES | GRUNENTHAL GMBH (DE) | 2010-01-14 | — | — | US | disclosed |
| EP-2044016-A2 | 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM | Grünenthal GmbH (DE) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008009415-A2 | 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1- AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM | Grünenthal GmbH (DE) | 2008-01-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009986-A1 | SUBSTITUTED HETEROARYL DERIVATIVES | CYP3A43, HMGCR, ABCG2 | OPRL1 1562/4885OPRM1 1029/4885OPRK1 532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.